Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sherry Pierce
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Improving Outcomes for Patients With Acute Myeloid Leukemia in First Relapse: A Single Center Experience
American Journal of Hematology
Hematology
Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology
Hematology
Factors Associated With Risk of Central Nervous System Relapse in Patients With Non-Core Binding Factor Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Prognosis of Patients With Intermediate Risk IPSS-R Myelodysplastic Syndrome Indicates Variable Outcomes and Need for Models Beyond IPSS-R
American Journal of Hematology
Hematology
Significance of Cytogenetic Abnormalities in Patients With Polycythemia Vera
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
1
2
3
›